Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Curated date: 2023/03/12
Curator: Dherahrose
Revision editor(s): LGeistlinger, Chloe, Dherahrose, Atrayees, Davvve, Folakunmi
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Posterior wall of oropharynx Posterior wall of oropharynx,posterior wall of oropharynx
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Acute respiratory distress syndrome acute lung injury,acute respiratory distress syndrome,ALI,ARDS,increased-permeability pulmonary edema,non-cardiogenic pulmonary edema,Shock lung,shock lung,Stiff lung,Acute respiratory distress syndrome
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Hyper-inflammatory subphenotype and ventilation-free days(VFDs)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mortality
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- patients stratified on the basis of 30-day mortality [survivors vs. non-survivors], for whom respiratory specimen cultures were reported as negative (no growth or only normal respiratory flora detected, n=152) as well as those for whom no cultures were obtained (n=76)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 228
- Group 1 sample size Number of subjects in the case (exposed) group
- 228
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- none
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Logistic Regression
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, chronic obstructive pulmonary disease, antibiotic exposure
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 1
Source: Supplementary figure E8
Description: Relative abundance of individual genera in Endotracheal aspirate (ETA) genera is associated with clinical outcomes and host-response subphenotypes in patients without positive respiratory cultures.
Abundance in Group 1: decreased abundance in Mortality
NCBI | Quality Control | Links |
---|---|---|
Prevotella |
Revision editor(s): Folakunmi
Experiment 2
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Epithelium of oropharynx Oropharyngeal epithelium,Oropharynx epithelial tissue,Oropharynx epithelium,Epithelium of oropharynx,epithelium of oropharynx
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Acute respiratory failure acute respiratory failure,respiratory failure, acute,Acute respiratory failure
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Hyper-inflammatory subphenotype and mortality
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- VFD (Ventilator free days)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Clinical outcome stratification by numbers of ventilator-free days (VFDs) at 30 days in patients for whom respiratory specimen cultures were reported as negative (no growth or only normal respiratory flora detected, n=152) as well as those for whom no cultures were obtained (n=76)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 1
Source: Supplementary figure E8
Description: Relative abundance of individual genera in Endotracheal aspirate (ETA) genera is associated with clinical outcomes and host-response subphenotypes in patients without positive respiratory cultures.
Abundance in Group 1: increased abundance in VFD (Ventilator free days)
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Streptococcus | ||
Veillonella | ||
Rothia | ||
Granulicatella | ||
unclassified Pasteurellaceae |
Signature 2
Source: Supplementary figure E8
Description: Relative abundance of individual genera in Endotracheal aspirate (ETA) genera is associated with clinical outcomes and host-response subphenotypes in patients without positive respiratory cultures.
Abundance in Group 1: decreased abundance in VFD (Ventilator free days)
NCBI | Quality Control | Links |
---|---|---|
Staphylococcus |
Experiment 3
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Endothelium of trachea Endothelium of windpipe,Trachea endothelium,Windpipe endothelium,Endothelium of trachea,endothelium of trachea
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- VFD (Ventilator free days) and mortality
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Hyper-inflammatory subphenotype
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- participants were classified into a hyperinflammatory subphenotype of host responses associated with worse outcomes in the pathogen-enriched cluster
- Group 0 sample size Number of subjects in the control (unexposed) group
- 112
- Group 1 sample size Number of subjects in the case (exposed) group
- 51
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes.
Abundance in Group 1: increased abundance in Hyper-inflammatory subphenotype
NCBI | Quality Control | Links |
---|---|---|
Fusobacterium | ||
unclassified Enterobacteriaceae | ||
unclassified Pseudomonadaceae | ||
Staphylococcus |
Revision editor(s): Folakunmi
Experiment 4
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Posterior wall of oropharynx Posterior wall of oropharynx,posterior wall of oropharynx
- Group 0 sample size Number of subjects in the control (unexposed) group
- 96
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes.
Abundance in Group 1: increased abundance in Hyper-inflammatory subphenotype
NCBI | Quality Control | Links |
---|---|---|
Lactobacillus |
Revision editor(s): Folakunmi
Experiment 5
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Hyper-inflammatory subphenotype and ventilation-free days(VFDs)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mortality
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- patients stratified on the basis of 30-day mortality [survivors vs. non-survivors]
- Group 0 sample size Number of subjects in the control (unexposed) group
- 92
- Group 1 sample size Number of subjects in the case (exposed) group
- 55
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes.
Abundance in Group 1: increased abundance in Mortality
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Streptococcus | ||
Veillonella | ||
Neisseria |
Revision editor(s): Folakunmi
Experiment 6
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Endothelium of trachea Endothelium of windpipe,Trachea endothelium,Windpipe endothelium,Endothelium of trachea,endothelium of trachea
- Group 0 sample size Number of subjects in the control (unexposed) group
- 111
- Group 1 sample size Number of subjects in the case (exposed) group
- 52
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, antibiotic exposure, chronic obstructive pulmonary disease
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes.
Abundance in Group 1: increased abundance in Mortality
NCBI | Quality Control | Links |
---|---|---|
Corynebacterium | ||
unclassified Eubacteriaceae |
Signature 2
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes.
Abundance in Group 1: decreased abundance in Mortality
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Haemophilus |
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Hyper-inflammatory subphenotype and mortality
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- VFD (Ventilator free days)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- clinical outcome stratifications by the number of days patients were ventilator-free
- Group 0 sample size Number of subjects in the control (unexposed) group
- 103
- Group 1 sample size Number of subjects in the case (exposed) group
- 60
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, chronic obstructive pulmonary disease, antibiotic exposure
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 1
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes.
Abundance in Group 1: increased abundance in VFD (Ventilator free days)
NCBI | Quality Control | Links |
---|---|---|
Staphylococcus |
Signature 2
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes.
Abundance in Group 1: decreased abundance in VFD (Ventilator free days)
NCBI | Quality Control | Links |
---|---|---|
Haemophilus | ||
Rothia | ||
Gemella | ||
Streptococcus | ||
Prevotella |
Experiment 8
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Posterior wall of oropharynx Posterior wall of oropharynx,posterior wall of oropharynx
- Group 0 sample size Number of subjects in the control (unexposed) group
- 106
- Group 1 sample size Number of subjects in the case (exposed) group
- 41
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 1
Source: Figure 4
Description: The relative abundance of individual genera is associated with clinical outcomes and host-response subphenotypes in oral swab samples genera
Abundance in Group 1: decreased abundance in VFD (Ventilator free days)
NCBI | Quality Control | Links |
---|---|---|
Granulicatella | ||
Neisseria | ||
Prevotella | ||
Rothia | ||
Streptococcus | ||
Veillonella | ||
unclassified Pasteurellaceae |
Revision editor(s): Folakunmi
Experiment 9
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Endothelium of trachea Endothelium of windpipe,Trachea endothelium,Windpipe endothelium,Endothelium of trachea,endothelium of trachea
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Hyper-inflammatory subphenotype and ventilation-free days(VFDs)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mortality
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- patients stratified on the basis of 30-day mortality [survivors vs. non-survivors] , for whom respiratory specimen cultures were reported as negative (no growth or only normal respiratory flora detected, n=152) as well as those for whom no cultures were obtained (n=76)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 228
- Group 1 sample size Number of subjects in the case (exposed) group
- 228
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 30 days
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 1
Source: Supplementary figure E8
Description: Relative abundance of individual genera in Endotracheal aspirate (ETA) genera is associated with clinical outcomes and host-response subphenotypes in patients without positive respiratory cultures.
Abundance in Group 1: decreased abundance in Mortality
NCBI | Quality Control | Links |
---|---|---|
Prevotella |
Revision editor(s): Folakunmi
Experiment 10
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Hyper-inflammatory subphenotype and mortality
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- VFD (Ventilator free days)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- clinical outcome stratifications by the number of days patients were ventilator-free for whom respiratory specimen cultures were reported as negative (no growth or only normal respiratory flora detected, n=152) as well as those for whom no cultures were obtained (n=76)
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- none
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 1
Source: Supplementary figure E8
Description: Relative abundance of individual genera in Endotracheal aspirate (ETA) genera is associated with clinical outcomes and host-response subphenotypes in patients without positive respiratory cultures.
Abundance in Group 1: decreased abundance in VFD (Ventilator free days)
NCBI | Quality Control | Links |
---|---|---|
Haemophilus | ||
Prevotella |
Revision editor(s): Folakunmi
Experiment 11
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- VFD (Ventilator free days) and mortality
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Hyper-inflammatory subphenotype
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- participants who were classified into a hyperinflammatory subphenotype of host responses, for whom respiratory specimen cultures were reported as negative (no growth or only normal respiratory flora detected, n=152) as well as those for whom no cultures were obtained (n=76)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Experiment 12
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Epithelium of oropharynx Oropharyngeal epithelium,Oropharynx epithelial tissue,Oropharynx epithelium,Epithelium of oropharynx,epithelium of oropharynx
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased